Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

INNATE PHARMA

(IPH)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur INNATE PHARMA
28/09NHTHERAGUIX : NH TherAguix announces the launch of -2-
20/09TODAY ON WALL STREET : The list of worries grows for investors
20/09ANALYST RECOMMENDATIONS : BHP, Lear, Naked Wines, Teradata, Visteon...
20/09BOLSA DE MADRID : Asia en aguas turbulentas
17/09NASDAQ 100 : Top Midday Gainers
17/09Wall Street Futures in Holding Pattern Ahead of Fed Meeting Next Week
17/09Top Premarket Gainers
17/09INNATE PHARMA : Monalizumab Data from COAST Trial Presented at ESMO Congress 2021 (Form 6-..
17/09INNATE PHARMA : Monalizumab Data from COAST Trial Presented at ESMO Congress 2021
15/09GLOBAL MARKETS LIVE : Microsoft, Apple, The Boeing Company, AT&T, Activision Blizzard...
15/09INNATE PHARMA : REPORTS FIRST HALF 2021 FINANCIAL RESULTS AND BUSINESS UPDATE (Form 6-K)
15/09Innate Pharma Posts Wider H1 2021 Net Loss, Revenue Falls
15/09INNATE PHARMA : Interim financial report 961.5 KB
15/09INNATE PHARMA : Reports First Half 2021 Financial Results and Business Update
15/09Innate Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
15/09Innate Pharma S.A. Announces Management Changes
13/09NH TherAguix registration document approved by -2-
07/09Top Premarket Decliners
07/09INNATE PHARMA S A : Top Brass to Offer H1 Business Update Next Week - Shares Drop in Pre-M..
07/09INNATE PHARMA : Announces Conference Call and Webcast for First Half 2021 Business Update ..
07/09INNATE PHARMA : Announces Conference Call and Webcast for First Half 2021 Business Update
03/09INNATE PHARMA S A : Shares Jump After SVB Leerink Upgrades Rating to Outperform
02/09INNATE PHARMA S A : Says AstraZeneca to Present Monalizumab Data at Oncology Conference; S..
02/09GLOBAL MARKETS LIVE : Ford, Walmart, Apple, Volkswagen, Tesla...
02/09INNATE PHARMA : AstraZeneca to present new data on monalizumab in combination with durvalu..
02/09INNATE PHARMA : Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual C..
30/08GLOBAL MARKETS LIVE : Sanofi, Walt Disney, Roche, Flatexdegiro, KBC Group...
30/08INNATE PHARMA : to Participate in Upcoming Investor Conferences (Form 6-K)
30/08INNATE PHARMA : to Participate in Upcoming Investor Conferences
16/07INNATE PHARMA : Corporate Presentation | July 2021
06/07GLOBAL MARKETS LIVE : Facebook, AngloGold, Didi, Weibo, Daimler...
06/07EN DIRECTO DESDE LOS MERCADOS : Welbilt, Google, Twitter, Alstom, AngloGold, Sicit, Volksw..
06/07INNATE PHARMA : Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe..
06/07INNATE PHARMA S A : Trial of Avdoralimab for COVID-19 Did Not Meet Goals; To Stop Explorat..
06/07INNATE PHARMA : to Stop Evaluating Antibody for COVID-19 After Mid-Stage Failure
06/07Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia
06/07Innate Pharma SA Announces Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patien..
22/06RESULTS PRESENTED AT 16TH INTERNATIO : 00 p.m. CEST / 8:00 a.m. EDT (Form 6-K)
22/06INNATE PHARMA : presents preliminary data from TELLOMAK trial showing clinical response fo..
22/06Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response f..
16/06GLOBAL MARKETS LIVE : Oracle, General Motors, Credit Suisse, Sony, Made.com...
16/06INNATE PHARMA : Company to highlight lacutamab data in mycosis fungoides and share data on..
16/06EN DIRECTO DESDE LOS MERCADOS : Solarpack, Oracle, Credit Suisse, EQT, eBay, Nintendo, Bla..
16/06Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Stra..
10/06INNATE PHARMA : Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 202..
10/06Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 20..
10/06Innate Pharma Molecule Shows Anti-Tumor Effect in Preclinical Studies
10/06Innate Pharma Presents New Data on Next-Generation NK Cell Engager Platform at FOCIS 20..
09/06INNATE PHARMA : New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentatio..
09/06New Lacutamab Data from TELLOMAK Trial to be Showcased in Oral Presentation at Upcoming..
09/06Innate Pharma S.A. Announces New Lacutamab Data from Tellomak Trial in Oral Presentatio..
03/06INNATE PHARMA : Assemblee Generale Mixte
31/05NHTHERAGUIX : NH TherAguix and the CHU Grenoble-Alpes announce the publication of the resu..
28/05INNATE PHARMA : Outcome of Innate Pharma's Annual General Meeting (Form 6-K)
28/05INNATE PHARMA : Outcome of Innate Pharma's Annual General Meeting
28/05INNATE PHARMA : Outcome of Innate Pharma's Annual General Meeting
28/05Marcus Schindler Decides Not to Seek Re-Election as Member of Supervisory Board of Inna..
20/05SEZARY SYNDROME PIPELINE : Emerging Therapies and Key pharma players involved by DelveInsi..
19/05INNATE PHARMA : Erratum (English Version)
14/05INNATE PHARMA : Virtual 2021 Annual General Meeting (Form 6-K)
12/05INNATE PHARMA : First Quarter 2021 Report (Form 6-K)
12/05Innate Pharma Virtual 2021 Annual General Meeting
11/05INNATE PHARMA : Corporate Presentation | May 2021
11/05¿Demasiado rápido, demasiado lejos, demasiado fuerte?
11/05Innate Pharma First Quarter 2021 Report
07/05INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (27 résolution) Stock options.pdf
07/05INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (28 résolution) AGA (Dir rém variabl..
07/05INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (29 résolution) AGA (Perf Dir).pdf
07/05INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (30 résolution) AGA (Perf Sal).pdf
07/05INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (31 résolution) PEE.pdf
07/05INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 (32 résolution) Réduction.pdf
07/05INNATE PHARMA : IPH 12.20 Rapport spécial AGE 05 2021 Conversion actions de préférence.pdf
04/05INNATE PHARMA : Announces Conference Call and Webcast for 2021 First Quarter Business Upda..
04/05INNATE PHARMA : 2021 Convening Notice
28/04INNATE PHARMA : Files its 2020 Universal Registration Document (Document d'Enregistrement ..
1  2  3  4  5  6  7  8  9Suiv.
Prochain événement sur INNATE PHARMA